SCHEMBL18409437

SCHEMBL18409437

CCc1cc(C)cc(F)c1Oc1cc2c(ncn2C)c(N(Cc2ccc(OC)cc2)Cc2ccc(OC)cc2)n1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CCNE2 O96020 2/20 0.33
▸ CCNE1 P24864 2/20 0.33
▸ CDK2 P24941 2/20 0.33
▸ F2RL3 Q96RI0 1/20 0.33
▸ PLA2G7 Q13093 2/20 0.33
▸ TSPO P30536 3/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ KDM4E B2RXH2 3/20 0.32
▸ GAA P10253 1/20 0.31
▸ NPY1R P25929 1/20 0.31
▸ NOS1 P29475 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398185 0.89 JAK2 (0.36) ALDH1A1SMN1; SMN2CCNE2CCNE1CDK2
SCHEMBL18398450 0.83 KDM4E (0.38) ALDH1A1SMN1; SMN2CCNE2CCNE1CDK2
SCHEMBL18398276 0.77 NSD2 (0.34) ALDH1A1SMN1; SMN2CCNE2CCNE1CDK2
SCHEMBL18409169 0.76 JAK2 (0.43) SMN1; SMN2L3MBTL1KDM4E
SCHEMBL18398537 0.74 CTSL (0.44) ALDH1A1CCNE2CCNE1CDK2KDM4E
SCHEMBL18409146 0.73 CCNE2 (0.42) ALDH1A1SMN1; SMN2CCNE2CCNE1CDK2
SCHEMBL18409435 0.68 JAK2 (0.37) —
SCHEMBL18398407 0.68 CCNE2 (0.37) ALDH1A1SMN1; SMN2CCNE2CCNE1CDK2
SCHEMBL18398457 0.67 CCNE2 (0.35) ALDH1A1SMN1; SMN2CCNE2CCNE1CDK2
SCHEMBL16909273 0.67 L3MBTL1 (0.50) ALDH1A1SMN1; SMN2CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback